ALTROPANE® SPECT Imaging in Patients With Parkinson Disease

NCT00397228 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: ALTROPANE®

Sponsor

Molecular NeuroImaging

Collaborators

[object Object]